Gapping up
In reaction to earnings/guidance:
- ANET +13.5%, VRNS +13.3%, AESI +11.4%, WWD +6.8%, FWRG +6.8%, GPN +6.6%, OSK +6.4%, ESPR +5.7%, SSTK +5%, HRMY +4.8%, SXC +4.2%, RYTM +4%, UBER +3.7%, PEG +3.5%, ARES +3%, ESAB +2.9%, SIRI +2.9%, AUDC +2.8%, DTM +2.8%, THC +2.4%, ETN +2.4%, TREX +2.3%, LDOS +2.2%, SBAC +2.1%, LEA +2.1%, AME +2.1%, KRC +2%, GDEN +2%, BHE +2%, CVI +2%, INCY +2%, CAT +1.9%, TM +1.8%, MRK +1.8%, KMT +1.7%, IGT +1.7%, TWO +1.6%, RSG +1.4%, BLMN +1.4%, SWK +1.2%, IT +1.2%, BP +1.1%, WELL +1%, LGIH +0.9%
Other news:
- EQRX +74.4% (Revolution Medicines (RVMD) to acquire EQRX in all-stock deal)
- EBS +12% (awarded 10-yr $704 mln max BARDA contract)
- INCY +2% (supply agreement with Replimune)
- KEN +1.6% (Kenon Holdings' OPC Energy announces update in respect of bid in an Israel Land Authority Tender to design and build electricity generation facilities using photovoltaic technology) LI +1.3% (July deliveries)
- SYNA +1.2% (adds new products to agreement with Broadcom)
- RWAY +1.2% (CEO taking temporary leave of absence)
Analyst comments:
- GPS +3.5% (upgraded to Overweight from Equal Weight at Barclays)
- BBWI +2.2% (upgraded to Overweight from Equal Weight at Barclays)
- AEO +2% (upgraded to Overweight from Equal Weight at Barclays)
- TPR +1.7% (upgraded to Overweight from Equal Weight at Barclays)